HLA-C and systemic lupus erythematosus: Because the concomitant administration of the K409A pep and Leader pep in lupus mice had a predominant effect of the mutant peptide, we assume that they compete for the same target on molecular and cellular levels, such as antigen presenting cells and MHC molecules.